| |
| |
|
| Insider
Information: |
Klausner Richard |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,990,681 |
|
|
Indirect Shares
|
930,880 |
|
|
| Direct
Value |
$10,603,385 |
|
|
|
Indirect Value
|
$2,578,538 |
|
|
| Total
Shares |
3,921,561 |
|
|
| Total
Value |
$13,181,923 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -36.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Illumina Inc |
ILMN |
Sr VP, Chief Medical O... |
2016-01-29 |
22,847 |
|
0 |
Premium* |
|
|
Juno Therapeutics, Inc. |
JUNO |
Director |
2018-03-05 |
0 |
|
0 |
Premium* |
|
|
Lyell Immunopharma, Inc. |
LYEL |
Director |
2023-08-15 |
2,967,834 |
2023-08-15 |
930,880 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
42 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2017-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
591 |
848,091 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2017-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
514 |
848,605 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2016-05-18 |
4 |
AS |
$40.00 |
$480,000 |
D/D |
(12,000) |
858,799 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2016-04-15 |
4 |
AS |
$42.79 |
$514,857 |
D/D |
(12,000) |
870,799 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2016-03-22 |
4 |
AS |
$40.00 |
$480,000 |
D/D |
(12,000) |
882,499 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2016-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
300 |
882,799 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2016-03-02 |
4 |
AS |
$40.39 |
$970,023 |
D/D |
(24,000) |
894,499 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2015-12-15 |
4 |
AS |
$44.81 |
$548,562 |
D/D |
(12,000) |
918,499 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2015-11-13 |
4 |
AS |
$49.48 |
$594,078 |
D/D |
(12,000) |
930,499 |
0 |
- |
|
| LYEL |
Lyell Immunopharma, Inc. |
Director |
– • – |
2023-08-15 |
4 |
S |
$2.28 |
$132,286 |
I/I |
(58,020) |
930,880 |
0 |
% |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2015-10-15 |
4 |
AS |
$50.00 |
$400,000 |
D/D |
(8,000) |
942,499 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2015-10-12 |
4 |
AS |
$50.00 |
$800,008 |
D/D |
(16,000) |
950,499 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2015-07-15 |
4 |
AS |
$53.33 |
$426,727 |
D/D |
(8,000) |
966,499 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2015-06-23 |
4 |
AS |
$51.98 |
$418,302 |
D/D |
(8,000) |
974,499 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2014-12-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
982,499 |
|
- |
|
| LYEL |
Lyell Immunopharma, Inc. |
Director |
– • – |
2022-09-23 |
4 |
S |
$6.40 |
$71,041 |
I/I |
(11,100) |
988,900 |
0 |
% |
|
| LYEL |
Lyell Immunopharma, Inc. |
Executive Chairman |
• • – |
2021-06-21 |
4 |
A |
$0.00 |
$0 |
I/I |
3,765,842 |
3,765,842 |
0 |
- |
|
42 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
